Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L.
Shinya Katsumata, Atsushi Kamigaichi, Takaki Akamine, Mitsuhiro Isaka, Masashi Wakabayashi, Noriko Mitome, Masaya Yotsukura, Takahiro Mimae, Aritoshi Hattori, Tomohiro Miyoshi, Makoto Endo, Kazuo Nakagawa, Hiroshige Yoshioka, Yasuhiro Tsutani, Tetsuya Isaka, Tomohiro Maniwa, Yoshihisa Shimada, Ryu Nakajima, Kenji Suzuki, Keiju Aokage, Hisashi Saji, Masahiro Tsuboi, Morihito Okada, Hisao Asamura, Yuta Sekino, Kenichi Nakamura, Haruhiko Fukuda, Shun-Ichi Watanabe
J Thorac Oncol 103916
摘要
摘要
INTRODUCTION: Segmentectomy has become a standard treatment for small-sized peripheral NSCLC. However, its advantages compared with lobectomy in NSCLC harboring pathologically invasive features remain unclear. METHODS: We conducted a post hoc supplementary analysis of randomized controlled phase 3 trial JCOG0802/WJOG4607L in patients with clinical stage IA NSCLC (≤2 cm) harboring one or more of the following pathologically invasive features: lymphatic, vascular, or pleural invasion and lymph node metastasis. The primary outcome was overall survival (OS), and secondary outcomes were relapse-free survival, cumulative incidence of locoregional relapse, lung cancer-specific death, and death from other causes. RESULTS: Of the 1106 participants randomly assigned to the lobectomy or segmentectomy arm, 298 (27%) were included in this analysis: 164 patients were in the lobectomy arm and 134 in the segmentectomy arm. At a median follow-up of 7.1 (interquartile range: 5.9-8.4) years, segmentectomy demonstrated a trend toward better OS than lobectomy, with hazard ratio (HR) of 0.657 (95% confidence interval [CI]: 0.401-1.077; p = 0.0936). The cumulative incidence of death from other causes was significantly reduced in the segmentectomy arm compared with the lobectomy arm (HR = 0.359 [95% CI: 0.143-0.900]). Relapse-free survival and cumulative incidence of lung cancer-specific death were not significantly different between the two arms, whereas the cumulative incidence of locoregional relapse was significantly higher in the segmentectomy than in the lobectomy arm (HR = 2.234 [95% CI: 1.334-3.741]). CONCLUSIONS: Segmentectomy demonstrated better OS compared with lobectomy even for NSCLC harboring pathologically invasive features. However, the risk of locoregional relapse after segmentectomy should be considered.
KM 提取结果
0 个 Figure · 0 个 KM 面板